Literature DB >> 844912

A 51chromium isotope release assay for detecting cytotoxicity to human bladder carcinoma.

C O'Toole.   

Abstract

A 51chromium isotope release assay is described for measuring in vitro cytotoxicity reactions against allogenetic target cells. Lymphoid cells from some patients with localized transitional cell carcinoma (TCC) were shown to selectively lyse targets derived from two long-term cell lines of TCC. The effector cells in this reaction did not form E rosettes. Cytotoxicity was successfully recovered after cryopreservation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 844912     DOI: 10.1002/ijc.2910190307

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

Review 1.  Serial immune function testing to predict clinical disease relapse in patients with solid tumors.

Authors:  D P Braun; J E Harris
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

2.  Serial immune testing in surgically resected lung cancer patients.

Authors:  D P Braun; S Nisius; A Hollinshead; J E Harris
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma.

Authors:  C O'Toole; Z H Price; Y Ohnuki; B Unsgaard
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.